593 related articles for article (PubMed ID: 33945523)
1. CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.
Malik N; Yan H; Yang HH; Ayaz G; DuBois W; Tseng YC; Kim YI; Jiang S; Liu C; Lee M; Huang J
PLoS Genet; 2021 May; 17(5):e1009553. PubMed ID: 33945523
[TBL] [Abstract][Full Text] [Related]
2. p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?
Wang C; Teo CR; Sabapathy K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079264
[TBL] [Abstract][Full Text] [Related]
3. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription.
Malik N; Yan H; Moshkovich N; Palangat M; Yang H; Sanchez V; Cai Z; Peat TJ; Jiang S; Liu C; Lee M; Mock BA; Yuspa SH; Larson D; Wakefield LM; Huang J
Nat Commun; 2019 May; 10(1):2071. PubMed ID: 31061501
[TBL] [Abstract][Full Text] [Related]
5. Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243
[TBL] [Abstract][Full Text] [Related]
6. New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma.
Gomes S; Raimundo L; Soares J; Loureiro JB; Leão M; Ramos H; Monteiro MN; Lemos A; Moreira J; Pinto M; Chlapek P; Veselska R; Sousa E; Saraiva L
Cancer Lett; 2019 Apr; 446():90-102. PubMed ID: 30664963
[TBL] [Abstract][Full Text] [Related]
7. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
8. The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells.
Dabiri Y; Kalman S; Gürth CM; Kim JY; Mayer V; Cheng X
Sci Rep; 2017 Jul; 7(1):5423. PubMed ID: 28710427
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells.
Meister MT; Boedicker C; Klingebiel T; Fulda S
Cancer Lett; 2018 Aug; 429():19-28. PubMed ID: 29702195
[TBL] [Abstract][Full Text] [Related]
10. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
[TBL] [Abstract][Full Text] [Related]
11. TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem-Like Cells in a Redox-Sensitive Manner.
Sharif T; Dai C; Martell E; Ghassemi-Rad MS; Hanes MR; Murphy PJ; Kennedy BE; Venugopal C; Subapanditha M; Giacomantonio CA; Marcato P; Singh SK; Gujar S
Clin Cancer Res; 2019 Mar; 25(6):2001-2017. PubMed ID: 30593514
[TBL] [Abstract][Full Text] [Related]
12. TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma.
Bae WK; Hong CS; Park MR; Sun EG; Lee JH; Kang K; Ryu KH; Shim HJ; Hwang JE; Cho SH; Chung IJ
Cancer Lett; 2018 Feb; 415():106-116. PubMed ID: 29222041
[TBL] [Abstract][Full Text] [Related]
13. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer.
Malik N; Kim YI; Yan H; Tseng YC; du Bois W; Ayaz G; Tran AD; Vera-Ramirez L; Yang H; Michalowski AM; Kruhlak M; Lee M; Hunter KW; Huang J
Cancer Res; 2023 Apr; 83(8):1280-1298. PubMed ID: 36799863
[TBL] [Abstract][Full Text] [Related]
15. XBP1-s promotes colorectal cancer cell proliferation by inhibiting TAp73 transcriptional activity.
Ji H; Huang C; Wu S; Kasim V
Biochem Biophys Res Commun; 2019 Jan; 508(1):203-209. PubMed ID: 30473215
[TBL] [Abstract][Full Text] [Related]
16. E1A activates transcription of p73 and Noxa to induce apoptosis.
Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
Guo L; Chen B; Zhang G; Wang Y; Cao L; Ren C; Wen L; Lin J; Wei G; Liao N
Gene; 2020 Oct; 759():144970. PubMed ID: 32711101
[TBL] [Abstract][Full Text] [Related]
18. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
[TBL] [Abstract][Full Text] [Related]
19. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.
Hsu CH; Ma HP; Ong JR; Hsieh MS; Yadav VK; Yeh CT; Chao TY; Lee WH; Huang WC; Kuo KT; Fong IH; Lin CC; Su CM
Dis Markers; 2022; 2022():8446629. PubMed ID: 35903297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
